[go: up one dir, main page]

MX9307309A - Derivados de pirrolo, su preparacion y su aplicacion en terapeutica. - Google Patents

Derivados de pirrolo, su preparacion y su aplicacion en terapeutica.

Info

Publication number
MX9307309A
MX9307309A MX9307309A MX9307309A MX9307309A MX 9307309 A MX9307309 A MX 9307309A MX 9307309 A MX9307309 A MX 9307309A MX 9307309 A MX9307309 A MX 9307309A MX 9307309 A MX9307309 A MX 9307309A
Authority
MX
Mexico
Prior art keywords
group
linear
branched
radical
alkyl
Prior art date
Application number
MX9307309A
Other languages
English (en)
Inventor
Juan Antonio Diaz Martin
Ulpiano Martin Escudero Perez
Manuel Bedoya Zurita
Gregorio Del Sol Moreno
Maria Dolores Jimenez Bargueno
Magali Romanach Ferrer
Mireille Sevrin
Jacques Menin
Christian Maloizel
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9214065A external-priority patent/FR2698364B1/fr
Priority claimed from FR9307538A external-priority patent/FR2706899A1/fr
Application filed by Synthelabo filed Critical Synthelabo
Publication of MX9307309A publication Critical patent/MX9307309A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La invención concierne derivados de pirrolo de fórmula general (I): en la cual: R1 representa un átomo de hidrógeno o de halógeno, un grupo C1-6-alquilo, lineal o ramificado, un grupo C3-6 alcenilo, un grupo C1-4 alcoximetilo, el radical benzilo, un grupo fenilo eventualmente substituido por uno o varios átomos de halógeno o radicales alquilo, un grupo CO2R, en el cual R representa un radical C1-4 alquilo lineal o ramificado, el radical fenilo o el radical benzilo, o un grupo CONR'R'' en el cual R' y R'' representan cada uno, independientemente uno del otro, un átomo de hidrógeno o un radical C1-4 alquilo lineal o ramificado. R2 representa un átomo de hidrógeno o de halógeno o un grupo C1-4 alquilo lineal o ramificado, y R3 representa un grupo 4,5-dihidro-1H-imidazol-2-ilo o 1H-imidazol-4-ilo, así como sus sales de adición a los ácidos farmacéuticamente aceptables. Se aplica en terapéutica.
MX9307309A 1992-11-24 1993-11-23 Derivados de pirrolo, su preparacion y su aplicacion en terapeutica. MX9307309A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9214065A FR2698364B1 (fr) 1992-11-24 1992-11-24 Dérivés de pyrrole, leur préparation et leur application en thérapeutique.
FR9307538A FR2706899A1 (en) 1993-06-22 1993-06-22 Pyrrole derivatives, their preparation and their therapeutic application

Publications (1)

Publication Number Publication Date
MX9307309A true MX9307309A (es) 1994-06-30

Family

ID=26229898

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9307309A MX9307309A (es) 1992-11-24 1993-11-23 Derivados de pirrolo, su preparacion y su aplicacion en terapeutica.

Country Status (16)

Country Link
US (1) US5380742A (es)
EP (1) EP0599697A1 (es)
JP (1) JPH06211869A (es)
KR (1) KR940011466A (es)
CN (1) CN1091743A (es)
AU (1) AU662846B2 (es)
CA (1) CA2109774A1 (es)
CZ (1) CZ252193A3 (es)
FI (1) FI935196L (es)
HU (1) HUT70504A (es)
IL (1) IL107726A (es)
MX (1) MX9307309A (es)
NO (1) NO934227L (es)
NZ (1) NZ250258A (es)
PL (1) PL301143A1 (es)
SK (1) SK130893A3 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2719844B1 (fr) * 1994-05-10 1996-06-07 Synthelabo Dérivés de 5,6-dihydro-4h-thiéno[3,4-c]pyrrole, leur préparation et leur application en thérapeutique.
DE19514579A1 (de) * 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz
FR2733750B1 (fr) * 1995-05-03 1997-06-13 Synthelabo Derives de l'acide gamma-oxo-alpha-(phenylmethyl)-5,6- dihydro-4h-thieno(3,4-c)pyrrole-5-butanoique, leur preparation et leur application en therapeutique
CA2327543A1 (en) * 1998-05-06 1999-11-11 Duke University Method of treating bladder and lower urinary tract syndromes
US8188126B2 (en) 2002-05-16 2012-05-29 Pierre Fabre Medicament Imidazolic compounds and use thereof as alpha-2 adrenergic receptors
JP2004035507A (ja) * 2002-07-05 2004-02-05 Nippon Soda Co Ltd ピロール誘導体及びその製造方法
CN101186612B (zh) * 2006-11-15 2012-10-03 天津和美生物技术有限公司 可抑制细胞释放肿瘤坏死因子的吡咯啉衍生物及其制备和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8529546D0 (en) * 1985-11-30 1986-01-08 Beecham Group Plc Compounds
FR2652579B1 (fr) * 1989-10-02 1992-01-24 Sanofi Sa Derives d'hydroxy-2 thiophene et furanne condenses avec un cycle azote, sur procede de preparation et leur application en therapeutique.
DE4023048A1 (de) * 1990-07-20 1992-01-23 Basf Ag Dicarbonsaeureimide, verfahren zu ihrer herstellung und ihre verwendung als herbizide
EP0600973A1 (en) * 1991-08-27 1994-06-15 The Upjohn Company A method for treatment of metabolic disorders and metabolism
US5252581A (en) * 1992-07-20 1993-10-12 Hoechst-Roussel Pharmaceuticals Inc. Substituted aminothienopyridines, pharmaceutical composition and use

Also Published As

Publication number Publication date
FI935196A7 (fi) 1994-05-25
IL107726A (en) 1997-01-10
PL301143A1 (en) 1994-05-30
AU662846B2 (en) 1995-09-14
HU9303322D0 (en) 1994-03-28
NO934227L (no) 1994-05-25
JPH06211869A (ja) 1994-08-02
CN1091743A (zh) 1994-09-07
EP0599697A1 (fr) 1994-06-01
AU5183193A (en) 1994-06-09
NZ250258A (en) 1995-07-26
FI935196A0 (fi) 1993-11-23
CA2109774A1 (fr) 1994-05-25
FI935196L (fi) 1994-05-25
HUT70504A (en) 1995-10-30
CZ252193A3 (en) 1994-06-15
KR940011466A (ko) 1994-06-21
NO934227D0 (no) 1993-11-23
US5380742A (en) 1995-01-10
SK130893A3 (en) 1994-11-09
IL107726A0 (en) 1994-02-27

Similar Documents

Publication Publication Date Title
AR009413A1 (es) Un compuesto, el cual es un derivado de distamicina benzoheterociclico, su utilizacion, un procedimiento para producirlo y una composicionfarmaceutica que lo comprende
DK34793A (da) Vandoploeseligt, farmaceutisk acceptabelt salt af et monoacylderivat af rapamycin, fremgangsmaade til dets fremstilling og injicerbart, farmaceutisk praeparat indeholdende det
ES2067456T3 (es) Nuevos derivados de aminoacidos, procedimientos para su preparacion y composicion farmaceutica que los comprende.
PA8472301A1 (es) Derivados de isotiazol utiles como agentes anticancerosos
ES2100907T3 (es) Bencimidazoles, medicamentos que contienen estos compuestos y proced imiento para su preparacion.
DK0591528T3 (da) Pyrazolo[1,5-a]pyrimidinderivat og antiinflammatorisk middel, der indeholder dette
UY25344A1 (es) Procedimiento para la preparacion de derivados de la tienopirimidina y de la tienopiridina utiles como agentes anticancerigenos
ES2114952T3 (es) Agentes antianginales derivados de quinazolinona.
MX2021011389A (es) Compuestos de imidazolonilquinolina y usos terapeuticos de los mismos.
ES2040879T3 (es) Procedimiento de preparacion de derivados pirimidinilaminicos de piperidina.
AR026352A1 (es) Derivados de imidazopiridina como inhibidores de la fosfodiesterasa vii.
CO4990933A1 (es) Derivados de indazol triciclicos, su preparacion y su apli- cacion en terapeutica
MX9206169A (es) Derivados de quinoleina, su preparacion y su aplicacion en terapeutica.
AR053149A1 (es) Uso de compuestos de diosmetina para la obtencion de composiciones farmaceuticas destinadas a la prevencion y/o tratamiento de patologias tromboticas y patologias que conlleven el riesgo de producir trombosis
ES2123873T3 (es) Pirrolocarbazol.
MX9307309A (es) Derivados de pirrolo, su preparacion y su aplicacion en terapeutica.
AR007997A1 (es) Un derivado de distamicina sustituida con acriloilo, sus utilizaciones, un procedimiento para producirlo y una composicion farmaceutica que lo comprende.
AR007108A1 (es) Agentes antitumorales y antivirales alquilantes, procedimiento para su preparacion, utilizacion de los mismos para la fabricacion de un medicamento y composicion farmaceutica que contiene a dichos agentes.
AR024146A1 (es) Derivados de 4-fenil-pirimidina
ES2086090T3 (es) Derivados de 4-pirimidinas, su preparacion y su aplicacion en terapeutica.
MX9303990A (es) Tetrazolil (fenoxi y fenoxialquil) piperidinil piridazinas como agentes antivirales.
MX9305932A (es) Derivados de piperidina, su preparacion y su aplicacion en terapeutica.
MX9203712A (es) Derivados de benzanilida y composiciones farmaceuticas que los contienen.
CO4750816A1 (es) Derivados de bencenosulfonamida, su preparacion y su aplicacion en terapeutica
YU45598B (sh) Bis-(piperazinil)-oz homopiperazinil)-alkani